Selegiline reduces daytime sleepiness in patients with Parkinson's disease

OBJECTIVES: Excessive daytime sleepiness (EDS) affects a large percentage of Parkinson's disease (PD) patients, and it is enhanced by dopamine agonist drugs. Currently, there is no treatment of choice for EDS in PD. Our aim was to check the clinical impression that some patients who were given...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallazzi, Marco, Mauri, Marco, Bianchi, Maria Laura, Riboldazzi, Giulio, Princiotta Cariddi, Lucia, Carimati, Federico, Rebecchi, Valentina, Versino, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119812/
https://www.ncbi.nlm.nih.gov/pubmed/33759401
http://dx.doi.org/10.1002/brb3.1880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119812/
https://www.ncbi.nlm.nih.gov/pubmed/33759401
http://dx.doi.org/10.1002/brb3.1880

Ejemplares similares